Tetracycline aptamer-controlled regulation of pre-mRNA splicing in yeast
暂无分享,去创建一个
[1] D. Askew,et al. Doxycycline-regulated gene expression in the opportunistic fungal pathogen Aspergillus fumigatus , 2005, BMC Microbiology.
[2] R. Breaker,et al. Immobilized RNA switches for the analysis of complex chemical and biological mixtures , 2001, Nature Biotechnology.
[3] Michael Müller,et al. Thermodynamic characterization of an engineered tetracycline-binding riboswitch , 2006, Nucleic acids research.
[4] Ronald R. Breaker,et al. Thiamine derivatives bind messenger RNAs directly to regulate bacterial gene expression , 2002, Nature.
[5] E. Buratti,et al. Influence of RNA Secondary Structure on the Pre-mRNA Splicing Process , 2004, Molecular and Cellular Biology.
[6] J. Venables. Aberrant and Alternative Splicing in Cancer , 2004, Cancer Research.
[7] M. Green,et al. Controlling gene expression in living cells through small molecule-RNA interactions. , 1998, Science.
[8] Jerry Pelletier,et al. Inhibition of translation by RNA-small molecule interactions. , 2002, RNA.
[9] Z. Dominski,et al. Restoration of correct splicing in thalassemic pre-mRNA by antisense oligonucleotides. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[10] Masatoshi Hagiwara,et al. Alternative splicing: a new drug target of the post-genome era. , 2005, Biochimica et biophysica acta.
[11] Thangavel Alphonse Thanaraj,et al. ASD: the Alternative Splicing Database , 2004, Nucleic Acids Res..
[12] Barbara Fink,et al. Tetracycline‐aptamer‐mediated translational regulation in yeast , 2003, Molecular microbiology.
[13] Nobuo Yamashita,et al. Thiamine‐regulated gene expression of Aspergillus oryzae thiA requires splicing of the intron containing a riboswitch‐like domain in the 5′‐UTR , 2003, FEBS letters.
[14] R. Gaur,et al. An artificial riboswitch for controlling pre-mRNA splicing. , 2005, RNA.
[15] Barbara Fink,et al. Molecular analysis of a synthetic tetracycline-binding riboswitch. , 2005, RNA.
[16] Barbara Fink,et al. Conditional gene expression by controlling translation with tetracycline-binding aptamers. , 2003, Nucleic acids research.
[17] S. Wilton,et al. RNA splicing manipulation: strategies to modify gene expression for a variety of therapeutic outcomes. , 2005, Current gene therapy.
[18] J. Friesen,et al. Effects on mRNA splicing of mutations in the 3' region of the Saccharomyces cerevisiae actin intron , 1987, Molecular and cellular biology.
[19] T. Cooper,et al. Pre-mRNA splicing and human disease. , 2003, Genes & development.
[20] Bosiljka Tasic,et al. Alternative pre-mRNA splicing and proteome expansion in metazoans , 2002, Nature.
[21] M. Garcia-Blanco,et al. Alternative splicing in disease and therapy , 2004, Nature Biotechnology.
[22] M. Gabut,et al. SR proteins as potential targets for therapy. , 2006, Progress in molecular and subcellular biology.
[23] R. Breaker,et al. Control of alternative RNA splicing and gene expression by eukaryotic riboswitches , 2007, Nature.
[24] G. Bellí,et al. An activator/repressor dual system allows tight tetracycline-regulated gene expression in budding yeast. , 1998, Nucleic acids research.
[25] R. Breaker,et al. Engineering precision RNA molecular switches. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[26] J. Venables. Unbalanced alternative splicing and its significance in cancer , 2006, BioEssays : news and reviews in molecular, cellular and developmental biology.
[27] D. Patel,et al. Adaptive recognition by nucleic acid aptamers. , 2000, Science.
[28] M. Rosbash,et al. Short artificial hairpins sequester splicing signals and inhibit yeast pre-mRNA splicing , 1993, Molecular and cellular biology.
[29] Piotr Borsuk,et al. l-Arginine influences the structure and function of arginase mRNA in Aspergillus nidulans , 2007, Biological chemistry.
[30] Jeffrey E. Barrick,et al. Metabolite-binding RNA domains are present in the genes of eukaryotes. , 2003, RNA.